Zheng Hou

Prof. Zheng Hou

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
BMBo Ma
Bo Ma
CFChao Fang
Chao Fang
LLLinshan Lu
Linshan Lu
MWMingzhi Wang
Mingzhi Wang
XXXiaoyan Xue
Xiaoyan Xue
ZHZheng Hou
Zheng Hou
New Delhi metallo-β-lactamase-1 (NDM-1) is the most prevalent type of metallo-β-lactamase and hydrolyzes almost all clinically used β-lactam antibiotics. Here we show that the antimicrobial peptide thanatin disrupts the outer membrane of NDM-1-producing bacteria by competitively displacing divalent cations on the outer membrane and inducing the release of lipopolysaccharides. In addition, thanatin inhibits the enzymatic activity of NDM-1 by displacing zinc ions from the active site, and reverses carbapenem resistance in NDM-1-producing bacteria in vitro and in vivo. Thus, thanatin’s dual mechanism of action may be useful for combating infections caused by NDM-1-producing pathogens.

24 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
DQDi Qu
Di Qu
ZHZheng Hou
Zheng Hou
JLJing Li
Jing Li
LLLiyang Luo
Liyang Luo
SSShan Su
Shan Su
MLMingkai Li
Mingkai Li
Coumarin compound DCH combats methicillin-resistant Staphylococcus aureus infection via inhibiting bacterial arginine repressor.

2 March 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YZYing Zhou
Ying Zhou
CNChao Niu
Chao Niu
BMBo Ma
Bo Ma
XXXiaoyan Xue
Xiaoyan Xue
ZLZhi Li
Zhi Li
ZHZheng Hou
Zheng Hou
Given its high resistance, enhanced virulence, and high transmissibility, community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) pneumonia is highly associated with high morbidity and mortality. Anti-virulence therapy is a promising strategy that bypasses the evolutionary pressure on the bacterium to develop resistance. RNAIII-inhibiting peptide (RIP), as an accessory gene regulator (agr)-specific inhibitor, significantly restricts the virulence of S. aureus and protects infected mice from death by blocking the agr quorum sensing system. The protective effects of RIP on the neutropenic mice completely disappeared in a neutrophil-deleted mouse infection model, but not in the macrophage-deleted mice. This result confirmed that the in vivo antibacterial activity of RIP is highly associated with neutrophil function. Phenol-soluble modulins (PSMs), as major leukocyte lysis toxins of CA-MRSA, are directly regulated by the agr system. In this experiment, PSMα1, 2, and 3 significantly induced neutrophil necroptosis by activating mixed lineage kinase-like protein (MLKL) phosphorylation and increasing lactate dehydrogenase release. The S. aureus supernatants harvested from the agr or psmα mutant strains both decreased the phosphorylation level of MLKL and cell lysis. PSMα1-mediated neutrophil lysis was significantly inhibited by necrosulfonamide, necrostatin-1, TNFα antibody, and WRW4. These results showed PSMα1 induced necroptosis depends on formylpeptide receptor 2 (FPR2)-mediated autocrine TNFα. Moreover, the neutrophil necroptosis induced by S. aureus was significantly suppressed and pneumonia was effectively prevented by the blockage of agrA and psmα expression levels. These findings indicate that PSMα-induced necroptosis is a major cause of lung pathology in S. aureus pneumonia and suggest that interfering with the agr quorum sensing signaling pathway is a potential therapeutic strategy.

1 January 2020 in Bio-Protocol
Verified
Journal Article
Closed access
BMBo Ma
Bo Ma
CFChao Fang
Chao Fang
JZJing Zhang
Jing Zhang
MWMingzhi Wang
Mingzhi Wang
XLXiaoxing Luo
Xiaoxing Luo
ZHZheng Hou
Zheng Hou
Bio-protocol is an online peer-reviewed protocol journal. Its mission is to make life science research more efficient and reproducible by curating and hosting high quality, free access protocols.

1 July 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
BMBo Ma
Bo Ma
CNChao Niu
Chao Niu
YZYing Zhou
Ying Zhou
XXXiaoyan Xue
Xiaoyan Xue
JMJingru Meng
Jingru Meng
ZHZheng Hou
Zheng Hou
Thanatin (THA) displays potent antibiotic activity, especially against extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli both in vitro and in vivo , with minimal hemolytic toxicity and satisfactory stability in plasma. However, the high cost of thanatin significantly limits its development and clinical application. To reduce the cost of peptide synthesis, a formulation of cyclic thanatin (C-thanatin) called linear thanatin (L-thanatin) was synthesized and its activity was evaluated in vivo and in vitro . Results showed that C-thanatin and L-thanatin MICs did not differ against eight Gram-negative and two Gram-positive bacterial strains. Furthermore, the survival rates of ESBL-producing- E. coli -infected mice were consistent after C-thanatin or L-thanatin treatment at 5 or 10 mg/kg of body weight. Neither C-thanatin nor L-thanatin showed toxicity for human red blood cells (hRBCs) and human umbilical vein endothelial cells (HUVECs) at a concentration as high as 256 μg/ml. Results of circular dichroism spectroscopy indicated that the secondary structure of L-thanatin is extremely similar to that of C-thanatin. Membrane permeabilization and depolarization assays showed that C-thanatin and L-thanatin have similar abilities to permeabilize the outer and inner membranes and to induce membrane depolarization in ESBL-producing E. coli . However, neither of them caused significant HUVEC membrane permeability. These findings indicate that the two peptides have similar effects on bacterial cell membranes and that the disulfide bond in thanatin is not essential for its antimicrobial activities in vivo and in vitro . L-thanatin is thus a promising low-cost peptide candidate for treating ESBL-producing E. coli infections.

26 June 2023 in EMBO Reports
Verified
Journal Article
Closed access
CFChao Fang
Chao Fang
PRPan Ren
Pan Ren
GBGanlan Bian
Ganlan Bian
JWJian Wang
Jian Wang
JBJiaxin Bai
Jiaxin Bai
ZHZheng Hou
Zheng Hou